FDA approves first flu vaccine that can be self-administered at home
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
Sierra Sun Times14h
FDA Approves FluMist Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
FDA approves first nasal spray flu vaccine for use at home
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...
STAT1d
FDA approves first at-home flu vaccine in U.S., a nasal spray
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
FDA approves first self-administered flu vaccine
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
MedPage Today1d
FDA OKs First Flu Vaccine for At-Home Use
The FDA approved FluMist for self- or caregiver-administration, making it the first influenza vaccine that does not need to ...
Daily20h
AstraZeneca FluMist gets USFDA nod for self-administered influenza vaccine
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
WBIW1d
FDA approves first nasal spray influenza vaccine for self or caregiver administration
INDIANA- Today, the U.S. Food and Drug Administration approved FluMist for self– or caregiver-administration. FluMist is ...
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
Monthly Prescribing Reference1d
FDA Approves Self-Administration of Influenza Vaccine FluMist
FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.